Amylyx Pharmaceuticals Aktie
WKN DE: A3DCEY / ISIN: US03237H1014
10.01.2025 01:49:43
|
Amylyx Pharma Commences Underwritten Public Offering Of Shares
(RTTNews) - Amylyx Pharmaceuticals Inc. (AMLX) announced that it has commenced an underwritten public offering of shares of its common stock.
In addition, Amylyx intends to grant the underwriter a 30-day option to purchase additional shares of its common stock in an amount up to 15% of the shares offered in the public offering at the public offering price per share, less underwriting discounts and commissions.
Amylyx noted that it plans to use the net proceeds from the offering, together with existing cash, cash equivalents and marketable securities, to advance preparations for commercialization and pipeline programs, for working capital and for general corporate purposes.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Amylyx Pharmaceuticals Inc Registered Shsmehr Nachrichten
03.03.25 |
Ausblick: Amylyx Pharmaceuticals öffnet die Bücher zum abgelaufenen Quartal (finanzen.net) | |
06.11.24 |
Ausblick: Amylyx Pharmaceuticals legt Quartalsergebnis vor (finanzen.net) |
Analysen zu Amylyx Pharmaceuticals Inc Registered Shsmehr Analysen
Aktien in diesem Artikel
Amylyx Pharmaceuticals Inc Registered Shs | 3,37 | -4,13% |
|